Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Bharati Bhardwaja
Patient Perspectives on Switching From Infliximab to Infliximab‐dyyb in Patients With Rheumatologic Diseases in the United States
ACR Open Rheumatology
Related publications
Efficacious Transition From Reference Infliximab to Biosimilar Infliximab in Clinical Practice
International Journal of Rheumatic Diseases
Rheumatology
Polyarthritis Flare in Patient With Ankylosing Spondylitis Treated With Infliximab
Reumatismo
Rheumatology
Switching Maintenance Infliximab Therapy to Biosimilar-Infliximab Does Not Lead to Significant Changes in Health-Related Quality of Life and Clinical Outcomes in Inflammatory Bowel Disease Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Serum Infliximab Level in an Infant Delivered From a Mother With Psoriatic Arthritis Receiving Infliximab
Journal of Dermatology
Dermatology
Medicine
Autoimmune Hepatitis Associated With Infliximab in a Patient With Psoriatic Arthritis
Annals of the Rheumatic Diseases
Immunology
Molecular Biology
Biochemistry
Rheumatology
Allergy
Genetics
Efficacy of Infliximab Biosimilars in Patients With Crohn's Disease
The Lancet
Medicine
Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
THU0218 the Efficacy and Drug Survival of the Biosimilar Infliximab (CT-P13) Compared to the Original Reference Infliximab in Inflammatory Rheumatic Diseases; Results From the Turkbio Registry
Ramsay Hunt Syndrome in a Patient With Rheumatoid Arthritis After Treatment With Infliximab
Case Reports in Rheumatology
